When pharmacotherapeutic recommendations may lead to the reverse effect on physician decision-making.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 2082656)

Published in Pharm World Sci on June 22, 2007

Authors

Abilio C de Almeida Neto1, Timothy F Chen

Author Affiliations

1: Faculty of Pharmacy, The University of Sydney, Sydney, NSW 2006, Australia. abilio@pharm.usyd.edu.au

Articles cited by this

From best evidence to best practice: effective implementation of change in patients' care. Lancet (2003) 27.61

Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial. Age Ageing (2006) 3.21

Pharmacy beyond the dispensary: general practitioners' views. BMJ (1992) 2.22

Reactance theory and patient noncompliance. Soc Sci Med (1997) 1.68

Collaborative drug therapy management by pharmacists--2003. Pharmacotherapy (2003) 1.48

Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol (2004) 1.31

Collaborative medication management services: improving patient care. Med J Aust (2002) 1.21

Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences. Arch Intern Med (1999) 1.18

Physicians' perceptions of communication with and responsibilities of pharmacists. J Am Pharm Assoc (Wash) (2000) 1.18

Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci (2007) 1.07

Is handwashing teachable?: failure to improve handwashing behavior in an urban emergency department. Acad Emerg Med (1996) 0.97

Hand hygiene--the case for evidence-based education. J R Soc Med (2001) 0.94

Counselling patients on psychotropic medication: physicians' opinions on the role of community pharmacists. Pharm World Sci (2000) 0.92

Where now for pharmacist led medication review? J Epidemiol Community Health (2006) 0.91

Articles by these authors

Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology (2012) 3.30

Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm (2005) 1.99

Quality patient care and pharmacists' role in its continuity--a systematic review. Ann Pharmacother (2009) 1.71

Pharmacy students' and graduates' attitudes towards people with schizophrenia and severe depression. Am J Pharm Educ (2006) 1.30

Interrater agreement and interrater reliability: key concepts, approaches, and applications. Res Social Adm Pharm (2012) 1.28

Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother (2008) 1.19

Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother (2009) 1.18

Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging (2008) 1.16

Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev (2013) 1.10

Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry (2008) 1.10

A comparative study of consumer participation in mental health pharmacy education. Ann Pharmacother (2006) 1.09

Concordance is not synonymous with compliance or adherence. Br J Clin Pharmacol (2007) 1.08

Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Aust New Zealand Health Policy (2005) 1.08

Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs Aging (2010) 1.07

Modifications to the drug burden index calculation may limit interpretation of its association with clinical outcomes in older adults. Neurocrit Care (2014) 1.07

Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci (2003) 1.06

Retrospective evaluation of home medicines review by pharmacists in older Australian patients using the medication appropriateness index. Ann Pharmacother (2010) 1.05

Attitudes of pharmacy students toward people with mental disorders, a six country study. Pharm World Sci (2008) 1.04

Developing the role of pharmacists as members of community mental health teams: perspectives of pharmacists and mental health professionals. Res Social Adm Pharm (2007) 1.01

Design and implementation of an educational partnership between community pharmacists and consumer educators in mental health care. Am J Pharm Educ (2006) 0.99

Impact of mental health first aid training on pharmacy students' knowledge, attitudes and self-reported behaviour: a controlled trial. Aust N Z J Psychiatry (2011) 0.95

Consumer-led mental health education for pharmacy students. Am J Pharm Educ (2010) 0.93

Drug related problems after discharge from an Australian teaching hospital. Pharm World Sci (2010) 0.92

Home medicines reviews: a quantitative study of the views of recipients and eligible non-recipients. Int J Pharm Pract (2011) 0.92

Pharmacists' beliefs about treatments and outcomes of mental disorders: a mental health literacy survey. Aust N Z J Psychiatry (2010) 0.92

A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners. J Eval Clin Pract (2010) 0.91

Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging (2009) 0.90

Patients' willingness to use a pharmacist-provided medication management service: the influence of outcome expectancies and communication efficacy. Res Social Adm Pharm (2012) 0.89

Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study. Am J Geriatr Pharmacother (2009) 0.88

Mental health consumers and caregivers as instructors for health professional students: a qualitative study. Soc Psychiatry Psychiatr Epidemiol (2011) 0.87

Assessing the harms of polypharmacy requires careful interpretation and consistent definitions. Br J Clin Pharmacol (2014) 0.87

An expert panel assessment of comprehensive medication reviews for clients of community mental health teams. Soc Psychiatry Psychiatr Epidemiol (2009) 0.86

Drug-related problems in the community setting: pharmacists' findings and recommendations for people with mental illnesses. Clin Drug Investig (2006) 0.86

Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev (2016) 0.86

Use of evidence-based therapy for the prevention of cardiovascular events among older people. Eval Health Prof (2010) 0.85

Are interventions recommended by pharmacists during Home Medicines Review evidence-based? J Eval Clin Pract (2010) 0.84

Evaluating the impact of direct and indirect contact on the mental health stigma of pharmacy students. Soc Psychiatry Psychiatr Epidemiol (2011) 0.83

An exploration of Australian hospital pharmacists' attitudes to patient safety. Int J Pharm Pract (2014) 0.82

Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people. J Clin Pharmacol (2009) 0.82

Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: a population-based retrospective cohort study. Can J Psychiatry (2011) 0.81

Multiple perspectives on shared decision-making and interprofessional collaboration in mental healthcare. J Interprof Care (2013) 0.81

Determinants of antipsychotic medication use among older people living in aged care homes in Australia. Int J Geriatr Psychiatry (2010) 0.81

Medication information seeking behavior of patients who use multiple medicines: how does it affect adherence? Patient Educ Couns (2013) 0.80

Shared decision-making and interprofessional collaboration in mental healthcare: a qualitative study exploring perceptions of barriers and facilitators. J Interprof Care (2013) 0.80

Impact of regulatory safety warnings on the use of antidepressants among children and adolescents in Finland. J Child Adolesc Psychopharmacol (2010) 0.79

A community pharmacist delivered adherence support service for dyslipidaemia. Eur J Public Health (2010) 0.79

Exploring patients' motivation to participate in Australia's Home Medicines Review program. Int J Clin Pharm (2012) 0.79

Adherence to antidepressant medications: an evaluation of community pharmacists' counseling practices. Patient Prefer Adherence (2013) 0.78

Mental health case conferences in primary care: content and treatment decision making. Res Social Adm Pharm (2007) 0.78

Improving medicine selection for older people - do we need an Australian classification for inappropriate medicines use? Aust Fam Physician (2012) 0.77

Use of consumer educators in mental health pharmacy education. Am J Pharm Educ (2009) 0.77

Effect of comorbidity on the risk of death associated with antipsychotic use among community-dwelling older adults. Int Psychogeriatr (2012) 0.77

Health care providers' perspectives of medication adherence in the treatment of depression: a qualitative study. Soc Psychiatry Psychiatr Epidemiol (2012) 0.77

Provision of a Medicines Information Service to Consumers on Facebook: An Australian Case Study. J Med Internet Res (2015) 0.77

Drug-related problems and the clinical role of pharmacists in inpatient mental health: an insight into practice in Australia. Int J Clin Pharm (2014) 0.77

Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol (2014) 0.76

Consumers' willingness to use a medication management service: the effect of medication-related worry and the social influence of the general practitioner. Res Social Adm Pharm (2012) 0.76

Factors associated with antipsychotic polypharmacy and high-dose antipsychotics among individuals receiving compulsory treatment in the community. J Clin Psychopharmacol (2014) 0.76

Application of a prescribing indicators tool to assist in identifying drug-related problems in a cohort of older Australians. Int J Pharm Pract (2011) 0.76

A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. Int J Clin Pharm (2013) 0.75

Unitary hormonal models, peripheral markers, and evaluation of response to drug: a response to Weisman and Feldman. Psychoneuroendocrinology (2013) 0.75

Consumer perceptions of using social media for health purposes: Benefits and drawbacks. Health Informatics J (2018) 0.75

Enhancing communication between hospital and community: multidisciplinary discharge case conferences. Pharm World Sci (2005) 0.75

Improving adherence to prescribed drugs. BMJ (2009) 0.75

"Order effect" in the provision of medication information. Med J Aust (2002) 0.75